These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 3416563
1. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1. Danpure CJ, Jennings PR. Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563 [Abstract] [Full Text] [Related]
2. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1. Cooper PJ, Danpure CJ, Wise PJ, Guttridge KM. J Histochem Cytochem; 1988 Oct; 36(10):1285-94. PubMed ID: 3418107 [Abstract] [Full Text] [Related]
3. An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria. Danpure CJ, Cooper PJ, Wise PJ, Jennings PR. J Cell Biol; 1989 Apr; 108(4):1345-52. PubMed ID: 2925788 [Abstract] [Full Text] [Related]
4. Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type 1. Wise PJ, Danpure CJ, Jennings PR. FEBS Lett; 1987 Sep 28; 222(1):17-20. PubMed ID: 2443389 [Abstract] [Full Text] [Related]
5. Fetal liver alanine: glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1. Danpure CJ, Jennings PR, Penketh RJ, Wise PJ, Cooper PJ, Rodeck CH. Prenat Diagn; 1989 Apr 28; 9(4):271-81. PubMed ID: 2717533 [Abstract] [Full Text] [Related]
6. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Danpure CJ. Am J Kidney Dis; 1991 Apr 28; 17(4):366-9. PubMed ID: 2008900 [Abstract] [Full Text] [Related]
7. Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity. Danpure CJ, Jennings PR, Watts RW. Lancet; 1987 Feb 07; 1(8528):289-91. PubMed ID: 2880111 [Abstract] [Full Text] [Related]
8. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease. Watts RW. Adv Enzyme Regul; 1992 Feb 07; 32():309-27. PubMed ID: 1496924 [Abstract] [Full Text] [Related]
10. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. Danpure CJ, Jennings PR. FEBS Lett; 1986 May 26; 201(1):20-4. PubMed ID: 3709805 [Abstract] [Full Text] [Related]
11. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1. Leiper JM, Oatey PB, Danpure CJ. J Cell Biol; 1996 Nov 26; 135(4):939-51. PubMed ID: 8922378 [Abstract] [Full Text] [Related]
12. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case. Nishiyama K, Funai T, Yokota S, Ichiyama A. J Cell Biol; 1993 Dec 26; 123(5):1237-48. PubMed ID: 8245128 [Abstract] [Full Text] [Related]
13. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, Lumb MJ, Guttridge KM, Jennings PR, Scheinman JI, Mauer SM. Am J Hum Genet; 1993 Aug 26; 53(2):417-32. PubMed ID: 8101040 [Abstract] [Full Text] [Related]
14. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B. Biochim Biophys Acta; 2013 Dec 26; 1832(12):2277-88. PubMed ID: 24055001 [Abstract] [Full Text] [Related]
15. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation. Purdue PE, Allsop J, Isaya G, Rosenberg LE, Danpure CJ. Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10900-4. PubMed ID: 1961759 [Abstract] [Full Text] [Related]
16. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. Purdue PE, Takada Y, Danpure CJ. J Cell Biol; 1990 Dec 01; 111(6 Pt 1):2341-51. PubMed ID: 1703535 [Abstract] [Full Text] [Related]
17. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver. Ichiyama A, Xue HH, Oda T, Uchida C, Sugiyama T, Maeda-Nakai E, Sato K, Nagai E, Watanabe S, Takayama T. Mol Urol; 2000 Dec 01; 4(4):333-40. PubMed ID: 11156700 [Abstract] [Full Text] [Related]
18. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. Fargue S, Knight J, Holmes RP, Rumsby G, Danpure CJ. Biochim Biophys Acta; 2016 Jun 01; 1862(6):1055-62. PubMed ID: 26854734 [Abstract] [Full Text] [Related]
19. Aminooxy acetic acid: a selective inhibitor of alanine:glyoxylate aminotransferase and its use in the diagnosis of primary hyperoxaluria type I. Andy V, Horváth P, Wanders RJ. Clin Chim Acta; 1995 Dec 29; 243(2):105-14. PubMed ID: 8747487 [Abstract] [Full Text] [Related]
20. Cytosolic compartmentalization of hepatic alanine:glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolism. Danpure CJ, Fryer P, Griffiths S, Guttridge KM, Jennings PR, Allsop J, Moser AB, Naidu S, Moser HW, MacCollin M. J Inherit Metab Dis; 1994 Dec 29; 17(1):27-40. PubMed ID: 8051936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]